A case study of haemoglobinopathy screening in the Netherlands: Witnessing the past, lessons for the future

Ethnicity and Health

Volumn 17, Issue 3, 2012, Pages 217-239

  Jans, Suze M P J ^a   Van El, Carla G ^a   Houwaart, Eddy S ^a   Westerman, Marjan J ^b   Janssens, Rien J P A ^a   Lagro Janssen, Antoinette L M ^c   Plass, Anne Marie C ^a   Cornel, Martina C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ethnicity; eugenics; haemoglobinopathy; reproductive choice; screening; sickle cell

Indexed keywords

AFRICAN AMERICAN; DECISION MAKING; ETHNICITY; FUTURE PROSPECT; HEALTH CARE; HEALTH POLICY; WAR;

ARTICLE; CONSENSUS DEVELOPMENT; DECISION MAKING; ETHNIC GROUP; ETHNOLOGY; GENETICS; HEALTH CARE POLICY; HEMOGLOBINOPATHY; HETEROZYGOTE; HUMAN; NETHERLANDS; NEWBORN; NEWBORN SCREENING; PATIENT ATTITUDE; POLITICS;

DECISION MAKING; ETHNIC GROUPS; HEALTH POLICY; HEMOGLOBINOPATHIES; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; POLITICS;

NETHERLANDS; UNITED STATES;

EID: 84863111617     PISSN: 13557858     EISSN: 14653419     Source Type: Journal    
DOI: 10.1080/13557858.2011.604126     Document Type: Article

References (78)

1. Achterbergh, R., et al., 2007. Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis. Health Policy, 83 (2-3), 277-286. (Pubitemid 47259215)
2. Aluoch, J.R., 1985. Sickle cell disease in the Netherlands. Origin, prevalence, clinical features and management. Thesis (PhD). University of Amsterdam.
3. Anionwu, E.N. and Atkin, K., 2001. The politics of sickle cell and thalassaemia. Buckingham, Philadelphia: Open University Press.
4. Baars, M.J., Henneman, L., and ten Kate, L.P., 2005. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genetics in Medicine, 7 (9), 605-610. (Pubitemid 41753011)
5. Baltesen, F. and Rijlaarsdam, B. 2008. Saving lives with discriminating registration [online]. NRC. Available from: www.nrc.nl [Accessed 14 May].
6. Blessing, M., 2005. The resistance against the census of 1971 [online]. Historisch Nieuwsblad, no. 8. Available from: www.historischnieuwsblad.nl
7. Bonham, V.L., Dover, G.J., and Brody, L.C., 2010. Screening student athletes for sickle cell trait-a social and clinical experiment. New England Journal of Medicene, 363 (11), 997-999.
8. Centre for Contemporary British History [CCBH], 2010. Oral History Programme [online]. Available from: www.ccbh.ac.uk/witnessseminars.php [Accessed 11 October 2010].
9. Commission of the Scientific Institute of the Christian Demoratic Party (chaired by Professor E. Bleumink), 1992. Genes and limits. The Hague: CDA.
10. Cornel, M.C., et al., 2009. To screen broader for haemoglobinopathy Medisch Contact, 45, 1874-1877.
11. Cornel, C, Dondorp, G., and de Wert, G., 2008. Allow parents the freedom to choose [online]. Trouw, 22 Nov. Available from www.trouw.nl
12. Cornel, M.C., Lakeman, P., and Dondorp, W., 2011. Do not postpone preconceptional carrier screening. Ned Tijdschr Geneeskd, 155, A3205.
13. de Jonge, A., 2005. Guidance on preconception care. Utrecht: KNOV.
14. de Walle, H.E., et al., 1999. Effect of mass media campaign to reduce socioeconomic differences in women's awareness and behaviour concerning use of folic acid: cross sectional study. BMJ, 319 (7205), 291-292. (Pubitemid 29353943)
15. de Wert, G.M.WR. and de Wachter, M.A.W, 1990. Can I have your gene-passport?. Baarn: Ambo.
16. de Wert, G.M.WR. and Engel, GL., 1988. Genetic counselling as instrument of population eugenics? Some remarks on the report 'Prevention congenital anomalies'. Medisch Contact, 43, 843-845.
17. Fraser, FC, 1974. Genetic counseling. American Journal of Human Genetics, 26 (5), 636-659.
18. Giordano, P.C., 1998. Haemoglobinopathies in the Netherlands. Diagnostics, epidemiology and prevention. Thesis (PhD). University of Leiden.
19. Giordano, P.C., 2006. Towards the state of the art neonatal screening for secondary and primary prevention of the hemoglobinopathies in The Netherlands. Validation of technology. Leiden: Leiden University Press.
20. Giordano, P.C., 2008. Doctors should enquire after the ethnicity of their patients [online]. News bulletin, Medisch Contact. Available from: http://medischcontact.artsennet.nl
21. Giordano, P.C., 2009. Starting neonatal screening for haemoglobinopathies in The Netherlands. Journal of Clinical Pathology, 62 (1), 18-21.
22. Giordano, P.C. and Harteveld, C.L., 2006. Prevention of hereditary haemoglobinopathies in The Netherlands. Ned Tijdschr Geneeskd, 150 (39), 2137-2141. (Pubitemid 44568578)
23. Giordano, P.C., et al., 2006. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study. Prenatal Diagnosis, 26 (8), 719-724. (Pubitemid 44252250)
24. Grey Literature Network Service, 2010. Homepage [online]. Available from: www.greynet.org [Accessed 14 June 2010].
25. Health Council of the Netherlands, 1989. Heredity: society and science. The Hague: Health Council of the Netherlands, Publication No. 1989/31.
26. Health Council of the Netherlands 2005. Neonatal screening. The Hague: Health Council of the Netherlands, Publication No. 2005/11.
27. Health Council of the Netherlands, 2007. Preconception care: a good beginning. The Hague: Health Council of the Netherlands, Publication No. 2007/19.
28. Hosli, E.J., et al., 2008. Women's motives for not participating in preconception counseling: qualitative study 150. Community Genetics, 11 (3), 166-170. (Pubitemid 351465620)
29. Huisman, T.H., van der Schaaf, P.C., and van der Sar, A., 1954. Studies on hemoglobin abnormality in sickle cell anemia and sickle cell trait. Ned Tijdschr Geneeskd, 98 (41), 2881-2888.
30. Jans, S. and Beentjes, M., 2010. Anaemia in midwifery practice: guideline. Utrecht: KNOV.
31. Jonxis, J.H., 1977. Hemoglobinopathies in families of foreign workers and other migrant groups. Ned Tijdschr Geneeskd, 121 (23), 949-954. (Pubitemid 8112037)
32. Kaizer, W., 1987. Better than God. Documentary. Netherlands: VPRO.
33. Kievits, F. and Adriaanse, M.T., 2007. Discrimination by inadequate care. Ned Tijdschr Geneeskd, 151, 778-779.
34. Klink, A., 2009. Answers to the queries from Koser Kaya, member of parliament, on preconceptional carrier screening. The Hague: National Government of the Netherlands, 2008Z08008/2080906580 Jan. 7.
35. Knoers, V.V.A.M. and Leschot, N.J., 2008. Genetics and ethnicity in letter to State Secretary of health, Wellbeing and Sports. PG/e 2807914. 22 January.
36. Lakeman, P., et al., 2006. Developing and optimizing a decisional instrument using self-reported ancestry for carrier screening in a multi-ethnic society. Genetics in Medicine, 8 (8), 502-509.
37. Lakeman, P., et al., 2008. Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine, 10 (11), 820-830.
38. Landman, H., 1988. Haemoglobinopathies and pregnancy. Thesis (PhD). University of Groningen.
39. Lanting, C.I., et al, 2008. Evaluation of the neonatal heelprick screening in infants born in 2007 [online]. Leiden: TNO Kwaliteit van Leven. Available from: www.rivm.nl/pns/Images/TNO%20Evaluatie%20hielprik%202008-tcm95- 56923.pdf [Accessed 22 July 2011].
40. Lenfant, C, 2003. Shattuck lecture: clinical research to clinical practice: lost in translation? New England Journal of Medicine, 349 (9), 868-874. (Pubitemid 37025407)
41. Mitchell, B.L., 2007. Sickle cell trait and sudden death-bringing it home. Journal of National Medical Association, 99 (3), 300-305. (Pubitemid 46399389)
42. Modell, B. and Darlison, M., 2008. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organisation, 86 (6), 480-487. (Pubitemid 351821761)
43. Muntinghe, O.G., Pietersz, R.N, and Verhulst, J.C., 1971. Hemoglobinopathies in immigrants from Surinam. Ned Tijdschr Geneeskd, 115 (31), 1306-1310.
44. National Institutes of Health, 1987. Newborn screening for sickle cell disease and other hemoglobinopathies. NIH Consensus Statement April 6-8; 6(9):1-22 [online]. Available from: http://consensus.nih.gov/1987/ 1987ScreeningSickleHemoglobinopathies061html.htm [Accessed 22 July 2011].
45. NHS Sickle Cell & Thalassaemia Screening Programme, 2011. Latest News [online]. Available from: http://sct.screening.nhs.uk/[Accessed 26 May 2011].
46. NRC, 2010. Christian Union wants to abolish 20 week ultra sound scan [online]. Available from: www.nrc.nl [Accessed 10 February 2010].
47. OSCAR, 2010. Homepage [online]. Available from: www.oscarnederland.nl [Accessed March 2011].
48. Overlegorgaan Caribische Nederlanders [OCaN], 2010. Homepage [online]. Available from: www.ocan.nl [Accessed 26 November 2010].
49. Peters, M., et al., 2009. Sickle cell disease in heel injection screening. I. Ned Tijdschr Geneeskd, 153 (18), 854-857.
50. Rengelink-van der Lee, J.H., van der Most van Spijk, M.W, and Schulpen, TW, 1994. National investigation into Sickle cell anaemia and Thalassaemia: Final Report. Utrecht, The Netherlands: Stichting Gezondheid Derde Wereld Kind.
51. Rip, A. and Kemp, R., 1998. Technological change. In: S. Rayner and E.L. Malone, eds. Human choice and climate change. Columbus, OH: Batelle Press, 327-399.
52. Schippers, E.I., 2010. Pregnancy and birth. Ministry of Health, Wellbeing and Sports, CZ/EKZ 3040205.
53. Schulpen, T.W, et al., 1998. Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune. Ned Tijdschr Geneeskd, 142 (18), 1019-1022. (Pubitemid 28204782)
54. Statistics Netherlands [CBS], 2010. Population [online]. Available from: www.cbs.nl [Accessed 11 October 2010].
55. Steering Committee Pregnancy and Childbirth, 2010. A good start: safe health care in pregnancy and childbirth. Final Report January 6.
56. Stein, R., 2010. Sickle cell testing of athletes stirs discrimination fears. Washington Post, 20 Sep.
57. Stirbu, I., et al., 2006. Differences in avoidable mortality between migrants and the native Dutch in The Netherlands. BMC Public Health, 6, 78.
58. Tapper, M., 1999. In the blood. Philadelphia: University of Pennsylvania Press.
59. The Dutch House of Representatives (Tweede Kamer der Staten Generaal), 1987. Prevention congenital abnormalities. Report No: TK 20345:2.
60. The Dutch House of Representatives (Tweede kamer der Staten Generaal) 1989-1990a. Population screening neural tube defects. Letter from The State Secretary of Welfare, Health and Culture. Parliamentary Documentation. TK 21353:1.
61. The Dutch House of Representatives (Tweede kamer der Staten Generaal). 1989-1990b. Population screening neural tube defects (Report of oral consultation). Parliamentary Documentation, TK 21353:2.
62. Troe, E.J., et al., 2006. Ethnic differences in total and cause-specific infant mortality in The Netherlands. Paediatric and Perinatal Epidemiology, 20 (2), 140-147.
63. van den Tweel, X., et al., 2006. Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptoms. European Journal Pediatrics, 165 (8), 581-582. (Pubitemid 43989423)
64. van der Sar, A., 1967. Aplastic sickle cell crisis: a report on four cases. Tropical and Geographical Medicine, 19 (4), 273-285.
65. van El, C.G., et al., 2010a. Debating about genetic screening criteria. Houten: Prelum Publishers.
66. van El, C.G., Pieters, T, and Cornel, M.C., 2010b. The changing focus of screening criteria in the age of genomics: a brief history from the Netherlands. In: B. Wieser and W Berger, eds. Assessing life: on the organisation of genetic testing. Munich, Vienna: Profil verlag, 203-224.
67. van Rhee, M.A., Holm, J.P, and Niermeijer, M.F., 1998. Genetic carrier screening for hemoglobinopathies: the situation in the Netherlands compared with England. Ned Tijdschr Geneeskd, 142 (18), 996-997.
68. Vansenne, F., et al., 2009. Sickle cell disease in heel injection screening II. Ned Tijdschr Geneeskd, 153 (18), 858-861.
69. van Wijk, M.A.M., et al., 2003. Anaemia: Guideline, M76. Utrecht: NHG
70. Wailoo, K. and Pemberton, P., 2006. The troubled dream of genetic medicine. Ethnicity and innovation in tay-sachs, cystic fibrosis and sickle cell disease. Baltimore: The John Hopkins University Press.
71. Weatherall, D.J. and Clegg, JB., 2001. Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization, 79 (8), 704-712. (Pubitemid 32776838)
72. Weinreich, S.S., et al., 2009. Raising awareness of carrier testing for hereditary haemoglobi-nopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers. BMC Public Health, 9, 338.
73. Wierenga, K.J., 1997. Neonatal screening for sickle-cell disease. Ned Tijdschr Geneeskd, 141 (4), 184-187.
74. Wierenga, K.J. and Luteijn, A.J, 1999. Heterozygote detection for hemoglobinopathies: situation in the Netherlands as compared to the British. Ned Tijdschr Geneeskd, 143 (6), 326-327.
75. Wilson, J.M.G. and Jungner, G, 1968. Principles and practice of screening for disease. Geneva: WHO.
76. World Health Organisation (WHO), 2006. Sickle cell anaemia. The 59th World Health Assembly. 117th session; Agenda item 4.8; Resolution EB117.R3.
77. World Health Organisation (WHO), 2008. Management of Hemoglobin disorders. Report of Joint WHO-TIF meeting, Nicosia Cyprus 16-18 November 2007. Geneva: WHO.
78. Zon MW (The Netherlands Organisation for Health Research and Development), 2009. Ethnicity and Health, ZonMw programme recommendations. April.